Published in Biotech Business Week, April 2nd, 2007
"Jim's vast business and development experience will be instrumental in guiding and helping Aegera meet its clinical and business objectives in the field of cancer and painrelated therapeutics", stated Dr. Michael Berendt, President and CEO of Aegera Therapeutics. "Furthermore, Jim's knowledge and network will be synergistic to that of our current Board members and I am looking forward to working closely with him to accelerate our company's growth objectives."
Mr. Rae has more than 40 years...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.